ENVB   $0.4  -4.76% Market Closed After Close 0.3951 -1.23%

Enveric Biosciences Inc
Total Cash 3.50M
totalCashPerShare 0.393
EBITDA -9.87M
Total Debt 0.00
quickRatio 5.891
currentRatio 8.554
Total Revenue
debtToEquity
Revenue/Share
ROA -0.80496
ROE -2.06101
grossProfits
freeCashflow -9.04M
operatingCashflow -9.98M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 647.89K
forwardPE -0.33
floatShares 8.64M
sharesOutstanding 8.92M
sharesShort 193.18K
sharesShortPriorMonth 204.65K
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.08%
heldPercentInstitutions 0.06%
Short Ratio help_outline 0.19%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 0.686
Price To Book help_outline 0.68
earningsQuarterlyGrowth
netIncomeToCommon -10.59M
trailingEps -3.45%
forwardEps -1.41%
enterpriseToEbitda -0.07
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.52 3Q 2024
institutionsCount 15
lastUpdated Nov. 7, 2024, 4:49 a.m.